Year archive

RAMM Pharma Corp. — 2025 filings

All 23 regulatory filings released by RAMM Pharma Corp. (RAMM) in 2025, sourced directly from the official regulator.

23 Filings

2025 Period

2025 filings (23)

Filing	Released	Lang
News release - English.pdf Proxy Solicitation & Information Statement	2025-11-07	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-09-27	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-09-27	English
Interim financial statements/report – English.pdf Interim / Quarterly Report 9M 2025	2025-09-27	English
Interim MD&A - English.pdf Management Reports	2025-09-27	English
Notice of the meeting and record date (amended) - English.pdf Proxy Solicitation & Information Statement	2025-07-25	English
Statement of executive compensation (form 51-102F6V) - English.pdf Remuneration Information	2025-06-27	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-06-27	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-06-27	English
Interim MD&A - English.pdf Management Reports	2025-06-27	English
Interim financial statements/report – English.pdf Interim / Quarterly Report H1 2025	2025-06-27	English
Notice of the meeting and record date - English.pdf Proxy Solicitation & Information Statement	2025-06-26	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-04-01	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-04-01	English
Interim MD&A - English.pdf Management Reports Q1 2025	2025-04-01	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q1 2025	2025-04-01	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2025-03-04	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2025-03-04	English
Annual MD&A - English.pdf Management Reports	2025-03-04	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-03-04	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-03-04	English
Audited annual financial statements – English.pdf Regulatory Filings	2025-03-04	English
News release - English.pdf M&A Activity	2025-01-21	English